Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
According to the FDA-approved prescribing information for Wegovy (semaglutide, current label on file with the FDA as of 2026) and Zepbound (tirzepatide, current label on file with the FDA as of 2026), both carry these warnings: A boxed warning - the FDA's most serious warning category - for thyroid C-cell tumors observed in rodent studies
Actual rates of alopecia were low, ranging from roughly 3 to 9 per 1,000 people per year, with between 11,000 and 15,000 people in each drug-class group
Do not take before bed
It has anti-inflammatory properties that reduce swelling and pain at injury sites
US$ 26.33
US$ 22.94
US$ 26.79
US$ 26.94
